2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Thomas Brian C. | Director | 2,514,790 | Dec 1, 2025 |
| Novo A/S | 10% Owner | 691,760 | Feb 15, 2024 |
| Bayer Healthcare Llc | — | 509,855 | Feb 15, 2024 |
| Bayer US Holding LP | — | 509,855 | Feb 15, 2024 |
| Bayer World Investments B.V. | — | 509,855 | Feb 15, 2024 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | Dec 8, 2025 | Thomas Brian C. | Director | Sell | 52.5 | -3,830 | -0.15% | ✗ | $6.8K |
| Dec 5, 2025 | Dec 8, 2025 | Wein Matthew | Officer | Sell | 52.5 | -199 | -0.17% | ✗ | $352.6 |
| Dec 5, 2025 | Dec 8, 2025 | Wapnick Pamela | CFO | Sell | 50.0 | -1,576 | -0.83% | ✗ | $2.8K |
| Dec 5, 2025 | Dec 8, 2025 | Irish Jian | CEO | Sell | 52.5 | -1,602 | -0.28% | ✗ | $2.8K |
| Sep 5, 2025 | Dec 1, 2025 | Thomas Brian C. | Director | Sell | 52.5 | -2,701 | -0.11% | ✗ | $4.9K |
| Sep 5, 2025 | Dec 1, 2025 | Wapnick Pamela | CFO | Sell | 90.0 | +118,424 | 164.23% | ✗ | $2.9K |
| Sep 5, 2025 | Dec 1, 2025 | Irish Jian | CEO | Sell | 90.0 | +246,898 | 77.51% | ✗ | $2.9K |
| Sep 5, 2025 | Dec 1, 2025 | Wein Matthew | Officer | Sell | 90.0 | +95,801 | 493.08% | ✗ | $360.2 |
| Sep 2, 2025 | Sep 2, 2025 | Reid Laurence | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 15, 2025 | Reid Laurence | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 10, 2025 | Jun 12, 2025 | Eckhardt Juergen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2025 | Jun 12, 2025 | Dere Willard H | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2025 | Jun 12, 2025 | BJERKHOLT ERIC | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2025 | Jun 9, 2025 | Wein Matthew | Officer | Sell | 47.5 | -199 | -1.18% | ✗ | $348.3 |
| Jun 6, 2025 | Jun 9, 2025 | Noonberg Sarah B. | Chief Medical Officer | Sell | 47.5 | -5,239 | -4.58% | ✗ | $9.2K |
| Jun 6, 2025 | Jun 9, 2025 | Wapnick Pamela | CFO | Sell | 47.5 | -1,576 | -2.14% | ✗ | $2.8K |
| Jun 6, 2025 | Jun 9, 2025 | Thomas Brian C. | CEO | Sell | 51.3 | -10,785 | -0.43% | ✗ | $18.9K |
| Jun 6, 2025 | Jun 9, 2025 | Irish Jian | Officer | Sell | 46.3 | -6,390 | -1.98% | ✗ | $11.2K |
| Apr 1, 2025 | Apr 3, 2025 | Wapnick Pamela | CFO | Neutral | 90.0 | +14,000 | 23.46% | ✗ | - |
| Apr 1, 2025 | Apr 3, 2025 | Thomas Brian C. | CEO | Neutral | 77.5 | +32,000 | 1.28% | ✗ | - |
| Apr 1, 2025 | Apr 3, 2025 | Irish Jian | Officer | Neutral | 82.5 | +23,000 | 3.51% | ✗ | - |
| Apr 1, 2025 | Apr 3, 2025 | Wein Matthew | Officer | Neutral | 90.0 | +7,425 | 78.43% | ✗ | - |
| Apr 1, 2025 | Apr 3, 2025 | Noonberg Sarah B. | Chief Medical Officer | Neutral | 90.0 | +14,000 | 13.95% | ✗ | - |
| Mar 5, 2025 | Mar 7, 2025 | Wein Matthew | Officer | Sell | 47.5 | -930 | -8.94% | ✗ | $1.7K |
| Mar 5, 2025 | Mar 7, 2025 | Wapnick Pamela | CFO | Sell | 47.5 | -1,808 | -2.94% | ✗ | $3.4K |
| Feb 3, 2025 | Feb 5, 2025 | BJERKHOLT ERIC | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 27, 2025 | BJERKHOLT ERIC | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 5, 2024 | Dec 6, 2024 | Wapnick Pamela | CFO | Sell | 47.5 | -1,559 | -2.47% | ✗ | $2.9K |
| Sep 5, 2024 | Sep 6, 2024 | Wapnick Pamela | CFO | Sell | 46.3 | -6,265 | -9.04% | ✗ | $18K |
| Apr 1, 2024 | Apr 3, 2024 | Irish Jian | Officer | Neutral | 90.0 | +70,471 | 12.04% | ✗ | - |
| Apr 1, 2024 | Apr 3, 2024 | Eckhardt Juergen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 1, 2024 | Apr 3, 2024 | Borges Luis | Chief Scientific Officer | Neutral | 90.0 | +69,316 | 100.00% | ✗ | - |
| Apr 1, 2024 | Apr 3, 2024 | Wein Matthew | Officer | Neutral | 90.0 | +10,397 | 100.00% | ✗ | - |
| Apr 1, 2024 | Apr 3, 2024 | Wapnick Pamela | CFO | Neutral | 90.0 | +69,316 | 100.00% | ✗ | - |
| Apr 1, 2024 | Apr 3, 2024 | Noonberg Sarah B. | Chief Medical Officer | Neutral | 90.0 | +57,763 | 135.56% | ✗ | - |
| Apr 1, 2024 | Apr 3, 2024 | Bernales Sebastian | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 1, 2024 | Apr 3, 2024 | Harnest Simon | Officer | Neutral | 90.0 | +11,552 | 10.40% | ✗ | - |
| Apr 1, 2024 | Apr 3, 2024 | Delaney Simren | Officer | Neutral | 85.0 | +6,931 | 7.97% | ✗ | - |
| Apr 1, 2024 | Apr 3, 2024 | Dere Willard H | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 1, 2024 | Apr 3, 2024 | Thomas Brian C. | CEO | Neutral | 85.0 | +118,992 | 5.01% | ✗ | - |
| Feb 9, 2024 | Feb 15, 2024 | Novo Holdings A/S | 10% Owner | Buy | 100.0 | +900,000 | 95.83% | ✗ | $13M |
| Feb 13, 2024 | Feb 15, 2024 | BAYER HEALTHCARE LLC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 15, 2024 | BAYER HEALTHCARE LLC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 13, 2024 | Feb 14, 2024 | Bernales Sebastian | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 8, 2024 | Novo Holdings A/S | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 8, 2024 | Wapnick Pamela | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 8, 2024 | Noonberg Sarah B. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 8, 2024 | Borges Luis | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 8, 2024 | Bernales Sebastian | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 8, 2024 | Harnest Simon | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 8, 2024 | Delaney Simren | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 8, 2024 | Eckhardt Juergen | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 8, 2024 | Wein Matthew | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 8, 2024 | Thomas Brian C. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 8, 2024 | Dere Willard H | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 8, 2024 | Irish Jian | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |